Write your message

XML Print


Department of Medical Mycology and Parasitology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.
Abstract:   (37 Views)
Acute respiratory coronavirus 2, the causative agent of the 2019 coronavirus disease (COVID-19), has been among the most important pathogens driving the healthcare delivery system in the past few years. Immunosuppressive drugs are used to treat this disease, and perhaps the nature of this disease has increased opportunistic infections in these patients. This study aims to investigate the number of fungal infections in patients with COVID-19. For this reason, keywords such as: “COVID-19”, “Aspergillus”, “fungi”, “Candida”, “Cryptococcus,” “Pneumocystis,” and “Mucorales” were searched. According to the investigation that was carried out, Aspergillus, Cryptococcus, Pneumocystis, Mucorales, and Candida were among the fungi that were investigated in patients with COVID-19. Lung damage, immunosuppression, need for oxygen therapy, steroid therapy, and hospitalization in intensive care units were known predisposing factors for fungal infections in these patients.
Full-Text [PDF 278 kb]   (23 Downloads)    
Type of Study: Research | Subject: Mycology
Received: 2024/02/27 | Accepted: 2024/06/23

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | International Journal of Medical Laboratory

Designed & Developed by : Yektaweb